Earnings Outlook For United Therapeutics
Portfolio Pulse from Benzinga Insights
United Therapeutics (NASDAQ:UTHR) is scheduled to release its quarterly earnings report on February 21, 2024. Analysts predict an EPS of $4.19. The company's past earnings performance shows a mix of beats and misses, with the last quarter beating estimates by $0.30, leading to a 1.83% share price increase the following day. Over the last year, UTHR shares have declined by 11.68%, indicating potential investor concern ahead of the earnings announcement. The focus will be on whether UTHR beats the EPS estimate and provides positive guidance for future growth.
February 20, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
United Therapeutics is expected to report an EPS of $4.19 for the upcoming quarter. Historical data shows variable stock price reactions to earnings reports. With shares down 11.68% over the last year, investor sentiment may be cautious.
Given United Therapeutics' mixed historical earnings performance and the recent downward trend in its stock price, the upcoming earnings report and future guidance will be crucial for investor sentiment. However, the exact impact on the stock price in the short term is uncertain, hence a neutral score.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100